PIPV Capital LLC 3
3 · IBERE PHARMACEUTICALS · Filed Feb 25, 2021
Insider Transaction Report
Form 3
PIPV Capital LLC
10% Owner
Holdings
Class B Ordinary Shares
→ Class A Ordinary Shares (3,350,000 underlying)
Footnotes (3)
- [F1]As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein.
- [F2]These shares represent Class B ordinary shares held by PIPV Capital LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer and a subsequent share dividend of Class B ordinary shares to the Sponsor. The Class B ordinary shares owned by the Sponsor includes up to 450,000 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the issuer's Registration Statement.
- [F3]These shares are held of record by the Sponsor. The Sponsor is beneficially owned and controlled by Lisa Gray, Osagie Imasogie, and Zoltan Kerekes, each of whom may be deemed to have beneficial ownership over these shares. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.